Kliničke studije za Мигрена u državi Њујорк
16 studija za Мигрена traži učesnike na lokacijama u državi Њујорк.
Gradovi u državi Њујорк
Zvanični tekst studije (na engleskom)
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nuvance Health Institute, Kingston
- Northwell Health, Manhasset
- Mt Sinai Icahn School of Medicine, New York
Тражи се учесникФаза 4
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06972056Study of EVO756 in Adults With Migraine
- Clinosis - Dent Neurologic Instite, Amherst
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 13. 11. 2026. · NCT07616128A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Dent Neuro Institute, Buffalo, Amherst
- SPRI Clinical Trials, LLC, Brooklyn
- True North Neurology, Commack
- и још 4
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- New York Neurology Associates, New York
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- Northwell Health IRB, Great Neck
- и још 4
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04649242Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Montefiore Medical Center, The Bronx
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 10. 2026. · NCT05156398A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- True North Neurology - Commack (North Suffolk Neurology), Commack
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 10. 2026. · NCT05164172A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Dent Neurologic Institute - Amherst /ID# 270260, Amherst
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06810505Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- SPRI Clinical Trials, Brooklyn
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 9. 10. 2026. · NCT07646613RELAXaHEAD for Headache Patients (Phase III)
- NYU Langone Health, New York
Тражи се учесник
Узраст од 16 до 80 · Оба пола · Ажурирано 8. 10. 2026. · NCT06077838Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
- Columbia University Irving Medical Center - NewYork Presbyterian Hospital (CUIMC/NYP), New York
Тражи се учесникФаза 3
Узраст од 18 до 55 · Оба пола · Ажурирано 8. 10. 2026. · NCT07629635A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- True North Neurology, Port Jefferson Station
Тражи се учесникФаза 1
Узраст од 6 до 11 · Оба пола · Ажурирано 28. 9. 2026. · NCT06995729A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
- Maimonides Medical Center, Brooklyn
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06473597Responding With Evidence and Access for Childhood Headaches
- Dent Neurological Institute, Amherst
Тражи се учесник
Узраст од 10 до 17 · Оба пола · Ажурирано 21. 9. 2026. · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Dent Neurologic Institute - Amherst /ID# 231182, Amherst
- SUNY Upstate Medical University /ID# 239898, Syracuse
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 9. 2026. · NCT05125302Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
- Neuroscience Institute at Great Neck, Great Neck
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 22. 5. 2026. · NCT07061847Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.